Jim Simons Neurocrine Biosciences Inc Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,251,646 shares of NBIX stock, worth $320 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
2,251,646
Previous 1,988,546
13.23%
Holding current value
$320 Million
Previous $262 Million
18.52%
% of portfolio
0.49%
Previous 0.41%
Shares
22 transactions
Others Institutions Holding NBIX
# of Institutions
630Shares Held
94.5MCall Options Held
505KPut Options Held
343K-
Black Rock Inc. New York, NY13.8MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.41 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$568 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$327 Million0.03% of portfolio
-
Morgan Stanley New York, NY2.07MShares$294 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...